Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma. Issue 3 (27th June 2021)

• Record Type: Journal Article
• Authors: Biran, Noa; Zhai, Wanting; Jensen, Roxanne E.; Mandelblatt, Jeanne; Kumka, Susan; Unawane, Rashmi; Graves, Kristi D.; Vesole, David H; Siegel, David S; Potosky, Arnold L.
• Is Part Of: EJHaem. Volume 2:Issue 3(2021)
• Page Start: 488
• Page End: 492
• Publication Date: 2021-06-27
• Subjects: autologous stem cell transplant -- cognitive function -- multiple myeloma -- patient‐reported outcomes -- quality of life; Hematology -- Periodicals; 616.15
• DOI: 10.1002/jha2.231
• Languages: English
• ISSNs: 2688-6146

Abstract

Abstract: We evaluated changes in patient‐reported outcomes and cognitive function from pre‐ to 3–6 months post‐treatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMIS‐29. There were statistically significant improvements in physical ( p < .001) and mental health ( p < .001) but not cognition from pre‐treatment to 3–6 month follow‐up. Similar results were seen within age or comorbidity strata. Patients with myeloma undergoing transplant experienced generally improved short‐term health outcomes with no significant declines in cognition.